Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. | 40,000 | reported | 10 Jun 2025 | tx 7+200,000 |
| ABIOMED INC | 27,081 | reported | 15 Jul 2017 | tx 10+97,498−5,492 |
| CRISPR Therapeutics AG | 26,891 | reported | 06 Aug 2021 | tx 25+462,119−99,352 |
| Acrivon Therapeutics, Inc. | 9,366 | reported | 18 May 2026 | tx 4+85,151 |
| CUBIST PHARMACEUTICALS INC | 0 | reported | 21 Jan 2015 | tx 51+91,883−180,042 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 9,366 | 0.00 USD | |
| 13 Jun 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 28 Aug 2024 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 35,235 | 0.00 USD | deriv |
| 19 Oct 2022 | PURCHASE | Milestone Pharmaceuticals Inc. | 15,000 | 5.32 USD | |
| 05 Jul 2022 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 06 Aug 2021 | EXERCISE | CRISPR Therapeutics AG | 25,000 | 17.75 USD | |
| 06 Aug 2021 | SALE | CRISPR Therapeutics AG | 19,011 | 138.22 USD | |
| 06 Aug 2021 | SALE | CRISPR Therapeutics AG | 5,989 | 139.46 USD | |
| 11 Mar 2021 | EXERCISE | CRISPR Therapeutics AG | 25,000 | 0.00 USD | deriv |
| 14 Jun 2021 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 30,000 | 0.00 USD | deriv |
| 10 Mar 2021 | TAX_WITHHOLDING | CRISPR Therapeutics AG | 1,352 | 124.15 USD | |
| 10 Mar 2021 | EXERCISE | CRISPR Therapeutics AG | 2,833 | — | |
| 11 Mar 2021 | GRANT_AWARD | CRISPR Therapeutics AG | 9,000 | 0.00 USD | deriv |
| 11 Mar 2021 | GRANT_AWARD | CRISPR Therapeutics AG | 25,360 | 0.00 USD | deriv |
| 05 Oct 2020 | GRANT_AWARD | CRISPR Therapeutics AG | 11,666 | 0.00 USD | deriv |
| 01 Sept 2020 | SALE | CRISPR Therapeutics AG | 2,800 | 91.39 USD | |
| 01 Sept 2020 | SALE | CRISPR Therapeutics AG | 2,800 | 93.18 USD | |
| 01 Sept 2020 | EXERCISE | CRISPR Therapeutics AG | 12,000 | 17.75 USD | |
| 01 Sept 2020 | SALE | CRISPR Therapeutics AG | 6,400 | 92.23 USD | |
| 01 Sept 2020 | EXERCISE | CRISPR Therapeutics AG | 12,000 | 0.00 USD | deriv |
| 03 Aug 2020 | EXERCISE | CRISPR Therapeutics AG | 12,000 | 17.75 USD |